During the past decade, Sanatorio San Jose conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sanatorio San Jose" are "Pulmonary Arterial Hypertension" (2 trials), "Caloric Deficit" (1 trials), "Digital Ulcers" (1 trials), "Malnutrition" (1 trials) and "Nutritional Status" (1 trials). Many other conditions were trialed in "Sanatorio San Jose" in a lesser frequency.

Most popular intervention types in "Sanatorio San Jose" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan 10 mg" (1 trials), "Macitentan 3 mg" (1 trials), "Treprostinil Diolamine" (1 trials) and "UT-15C (treprostinil diolamine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio San Jose" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio San Jose". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sanatorio San Jose, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio San Jose, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".